ArticleERJ open research2026

Real-world effectiveness of biologic therapies in severe asthma patients ineligible for phase 3 randomised controlled trials of biologics: an analysis from the UK Severe Asthma Registry.

Paul E Pfeffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.